EMTAX
Price
$9.01
Change
-$0.00 (-0.00%)
Updated
Apr 2 closing price
Net Assets
260.6M
MEDHX
Price
$12.03
Change
+$0.03 (+0.25%)
Updated
Apr 1 closing price
Net Assets
7.12B
Ad is loading...

EMTAX vs MEDHX

Header iconEMTAX vs MEDHX Comparison
Open Charts EMTAX vs MEDHXBanner chart's image
Transamerica Emerging Markets Debt A
Price$9.01
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets260.6M
MFS Emerging Markets Debt R6
Price$12.03
Change+$0.03 (+0.25%)
VolumeN/A
Net Assets7.12B
EMTAX vs MEDHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMTAX vs. MEDHX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMTAX is a Hold and MEDHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
MEDHX has more cash in the bank: 7.12B vs. EMTAX (261M). EMTAX (6.90) and MEDHX (6.87) have matching dividends . EMTAX was incepted earlier than MEDHX: EMTAX (14 years) vs MEDHX (19 years). EMTAX (1.40) is less costly to investors than MEDHX (0.71). EMTAX is a more actively managed with annual turnover of: 151.00 vs. MEDHX (58.00). MEDHX has a lower initial minimum investment than EMTAX: MEDHX (0) vs EMTAX (1000). MEDHX annual gain was more profitable for investors over the last year : 7.29 vs. EMTAX (4.75). EMTAX return over 5 years is better than : 26.35 vs. MEDHX (24.96).
EMTAXMEDHXEMTAX / MEDHX
Total Expense Ratio1.250.70179%
Annual Report Gross Expense Ratio1.400.71197%
Fund Existence14 years19 years-
Gain YTD1.8322.27680%
Front Load5%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets261M7.12B4%
Annual Yield % from dividends6.906.87100%
Returns for 1 year4.757.2965%
Returns for 3 years9.3412.5075%
Returns for 5 years26.3524.96106%
Returns for 10 years30.5038.1080%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADNIX13.200.07
+0.53%
American Beacon ARK Transfmt Innov R5
UUPSX48.93N/A
N/A
ProFunds UltraEmerging Markets Svc
FBTAX25.89N/A
N/A
Fidelity Advisor Biotechnology A
ATHGX25.18N/A
N/A
American Century Heritage R5
IEMFX32.12N/A
N/A
T. Rowe Price Instl Emerging Mkts Eq